Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Dr Tochi Okwuosa: Multidisciplinary Collaboration Vital for Preventing Cardiac Damage From Cancer CareFebruary 4th 2023
Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical, discusses the multidisciplinary process that underlies caring for patients with cancer who may develop heart damage.
AD Progression Adversely Influenced by Outdoor Air PollutionFebruary 2nd 2023
With atopic dermatitis (AD) prevalence increasing around the world, primarily in developing countries, investigators evaluated the potential for pollution to have an impact on development of the chronic skin condition among an adult population.
Periostin Bests Eosinophil Count for Biomarker Predictability in ECRSFebruary 2nd 2023
Known to be a contributing factor to polyp development at high levels, periostin’s potential as a biomarker for eosinophilic chronic rhinosinusitis (ECRS) severity was investigated in a new study in which outcomes were compared between patients who had ECRS and those with non-ECRS.
ACAAI Report Highlights AD, Allergy Care Disparities and Proposed SolutionsJanuary 24th 2023
Following member surveys, expert interviews, and roundtable discussions, the American College of Allergy, Asthma, and Immunology (ACAAI) has released new recommendations for overcoming care disparities among those who have atopic dermatitis (AD) and food allergies.
Dr Michael Portman Illuminates the Differences Between Pediatric, Adult Anticoagulation StudiesJanuary 23rd 2023
Pharmaceutical companies would have to spend a lot of money on pediatric anticoagulation studies for diseases that are rare among these patients, explained Michael A. Portman, MD, FAHA, of Seattle Children's Hospital.
Early Diagnosis Vital to Prevent Impairment From Pediatric EGIDsJanuary 20th 2023
Although it is well studied in adult patients, there is a lack of research on eosinophilic gastrointestinal disorders (EGIDs) among pediatric patients; a recent study aimed to add to the clinical knowledge of EGIDs in younger patients.
Adherence to Postop Treatment May Indicate Early Recurrence of CRSwNPJanuary 17th 2023
The utility of and adherence to follow-up exams for potential recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) was investigated among 60 patients who had undergone functional endoscopic sinus surgery.
Dr Michael Portman Explains How Cardiac Disease Differs Between Pediatric, Adult PatientsJanuary 16th 2023
During an interview at the 2022 American Heart Association Scientific Sessions in Chicago, Michael A. Portman, MD, FAHA, Seattle Children's Hospital addressed how cardiac disease presents in pediatric vs adult patients.
Stress Management Important for Mothers of Pediatric Patients With Atopic DermatitisJanuary 12th 2023
The parents of pediatric patients who have atopic dermatitis experience stress just as their children do, and this study investigated how that stress manifests among the parents, comparing outcomes between mothers and fathers.
Eczema Exhibits Potential Protection Against Brain Cancer DevelopmentJanuary 11th 2023
For 2 important reasons—that brain cancer is so aggressive and its risk may be elevated in the presence of certain allergies—investigators of a meta-analysis set out to investigate potential connections between eczema and various brain cancers.
Interleukin-13, Periostin Show Potential as Biomarkers in Prurigo NodularisJanuary 7th 2023
Levels of certain biomarkers of inflammation in prurigo nodularis were evaluated between patients with and without the chronic inflammatory skin disorder, with the goal of showing potential for precision medicine in prurigo nodularis.
Allina Health’s Mike Koroscik on Helping Patients Navigate Cancer-Related Financial ToxicityJanuary 6th 2023
We want to make it easy for our patients to manage and navigate the financial toxicity they encounter from their cancer care, noted Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health and the Allina Health Cancer Institute.
Risk of EoE Elevated Following Care for Previous InfectionJanuary 6th 2023
With previous research showing that having a history of infection can lead to loss of autoimmunity, Swedish researchers set out to investigate a potential link between prior infection and development of eosinophilic esophagitis (EoE).
Sacubitril/Valsartan Safe, Effective for Patients With HFpEF Undergoing MHDJanuary 6th 2023
The efficacy and safety of sacubitril/valsartan, the angiotensin receptor neprilysin inhibitor, was investigated among a patient population who had heart failure with preserved ejection fraction (HFpEF) and currently receiving maintenance hemodialysis (MHD).
ChristianaCare’s Debra Delaney on the Importance of Mental Health Care AwarenessJanuary 5th 2023
There are still barriers to mental health care, in both the medical and outside worlds, noted Debra Delaney, MSN, FNP-BC, primary care nurse practitioner at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute.
Self-care for Atopic Dermatitis Potentially Feasible as Treatment InterventionJanuary 4th 2023
With mixed findings from previous studies focused on atopic dermatitis and the use of cognitive behavioral therapy (CBT) as a treatment modality, investigators modified an existing online CBT intervention to account for the lack of clinical psychologists in the dermatological space.